-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Experimental and observational studies have shown that vitamin D and medsci.
Vitamin D medsci.
Recently, a research article published in JAHA, an authoritative journal in the field of cardiovascular diseases, researchers tried to determine whether vitamin D supplementation can reduce insulin resistance, inflammation, neurohormonal activation, and lipid biomarkers.
This study is a pre-determined secondary analysis of a randomized controlled trial of vitamin D treatment (DAYLIGHT) in high-risk groups of hypertension.
Compared with the low-dose vitamin D treatment group, the 25-OH-D level in the high-dose group increased (+15.
It can be seen that high-dose vitamin D supplementation cannot improve blood sugar, inflammation, neurohormonal activation or lipid biomarkers .
High-dose vitamin D supplementation does not improve blood sugar, inflammation, neurohormonal activation, or lipid biomarkers
Original source:
Original source:Jennifer Miao.